Post-implantation syndrome following endovascular abdominal aortic aneurysm repair: preliminary data
| dc.contributor.author | Arnaoutoglou, E. | en |
| dc.contributor.author | Kouvelos, G. | en |
| dc.contributor.author | Milionis, H. | en |
| dc.contributor.author | Mavridis, A. | en |
| dc.contributor.author | Kolaitis, N. | en |
| dc.contributor.author | Papa, N. | en |
| dc.contributor.author | Papadopoulos, G. | en |
| dc.contributor.author | Matsagkas, M. | en |
| dc.date.accessioned | 2015-11-24T18:57:42Z | |
| dc.date.available | 2015-11-24T18:57:42Z | |
| dc.identifier.issn | 1569-9285 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/19195 | |
| dc.rights | Default Licence | - |
| dc.subject | Aged | en |
| dc.subject | Aged, 80 and over | en |
| dc.subject | Aortic Aneurysm, Abdominal/*surgery | en |
| dc.subject | Blood Vessel Prosthesis Implantation/*adverse effects | en |
| dc.subject | Chi-Square Distribution | en |
| dc.subject | Endovascular Procedures/*adverse effects | en |
| dc.subject | Female | en |
| dc.subject | Greece | en |
| dc.subject | Humans | en |
| dc.subject | Inflammation Mediators/blood | en |
| dc.subject | Length of Stay | en |
| dc.subject | Male | en |
| dc.subject | Middle Aged | en |
| dc.subject | Pilot Projects | en |
| dc.subject | Prospective Studies | en |
| dc.subject | Systemic Inflammatory Response Syndrome/blood/*etiology/immunology | en |
| dc.subject | Time Factors | en |
| dc.subject | Treatment Outcome | en |
| dc.title | Post-implantation syndrome following endovascular abdominal aortic aneurysm repair: preliminary data | en |
| heal.abstract | OBJECTIVES: Endovascular aneurysm repair (EVAR), may elicit an unexpected systemic inflammatory response, which has been named post-implantation syndrome (PIS). The aim of this study was to prospectively evaluate the association of PIS with clinical and laboratory parameters in patients who underwent EVAR for abdominal aortic aneurysms (AAA). METHODS: Forty consecutive patients who underwent EVAR for AAA were studied. Complete blood count, fibrinogen, high sensitivity C-reactive protein (hs-CRP), interleukin (IL)-6, IL-1, tumor necrosis factor-alpha were determined before and after surgery. Several parameters regarding the operation, as well as the hospitalization days were recorded. RESULTS: PIS was diagnosed in 35% of the patients. Patients with PIS showed significant greater changes of inflammation marker levels, including hs-CRP and IL-6, as compared with the non-PIS group. PIS was associated with longer hospitalization. CONCLUSION: PIS is a relatively common complication of EVAR used to treat AAAs and it is associated with features of a systemic inflammatory response and prolongation of hospitalization. Further studies are necessary towards understanding the underlying pathophysiology and evaluating effective preventive strategies. | en |
| heal.access | campus | - |
| heal.fullTextAvailability | TRUE | - |
| heal.identifier.primary | 10.1510/icvts.2010.256784 | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/21248083 | - |
| heal.identifier.secondary | http://icvts.oxfordjournals.org/content/12/4/609.full.pdf | - |
| heal.journalName | Interact Cardiovasc Thorac Surg | en |
| heal.journalType | peer-reviewed | - |
| heal.language | en | - |
| heal.publicationDate | 2011 | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.type | journalArticle | - |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή:
